Target intelligence / Profile preview

Exportin-1 (XPO1) receptor (XPO1)

Target
XPO1
Molecular classification
Transporter, Receptor, Karyopherin
01

Overview

Exportin-1 (XPO1), also known as Chromosome Region Maintenance 1 (CRM1), is a critical nuclear export receptor belonging to the karyopherin beta family [UniProt]. It mediates the transport of over 200 cargo proteins, including tumor suppressor proteins (TSPs) such as p53, p21, and BRCA1, from the nucleus to the cytoplasm [PubMed: 30104729]. In many cancers, XPO1 is overexpressed, leading to the excessive export and subsequent inactivation of these TSPs in the cytoplasm, which promotes uncontrolled cell proliferation and survival [StatPearls]. Therapeutic targeting of XPO1 with Selective Inhibitors of Nuclear Export (SINE), such as selinexor, forces the nuclear retention and reactivation of these tumor suppressors, inducing apoptosis in malignant cells while sparing normal cells [FDA]. This mechanism has proven effective in treating hematologic malignancies like multiple myeloma and diffuse large B-cell lymphoma, and is currently being explored in various solid tumors [NCI].

Other names
CRM1Chromosome region maintenance 1Exp1Exportin 1
02

Mechanism of action

Selective inhibition of nuclear export (SINE) via covalent binding to the cysteine 528 residue in the cargo-binding pocket of XPO1, preventing the export of tumor suppressor proteins and other regulatory factors [PubMed: 29335501].

03

Biological functions

Nuclear-cytoplasmic transportCell cycle regulationApoptosis regulationProtein localization
04

Disease associations

CancerMultiple myelomaDiffuse large B-cell lymphomaSolid tumorViral infection
05

Safety considerations

Thrombocytopenia [FDA]Nausea [FDA]Vomiting [FDA]Fatigue [FDA]Hyponatremia [FDA]Neutropenia [FDA]Decreased appetite [FDA]
06

Interacting drugs

Selinexor [FDA]

3 more in the full profile.

07

Biomarkers

XPO1 overexpression [PubMed: 30104729]Nuclear localization of p53 [PubMed: 29335501]Nuclear localization of p21 [PubMed: 29335501]

Beyond the preview

Go deeper on Exportin-1 (XPO1) receptor (XPO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exportin-1 (XPO1) receptor (XPO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call